Select a Region

North America

Newscenter

Read our latest news!

Posted on January 5, 20221/5/22

OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders

Posted on December 21, 202112/21/21

EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization

Posted on December 16, 202112/16/21

EVERSANA Announces Real-World Data Agreement with Janssen to Augment Development of Chronic Disease Care Therapies

Posted on December 13, 202112/13/21

EVERSANA’s Omnichannel Activation Model Named One of The Most Innovative Strategies of 2021 by PM360

Posted on November 23, 202111/23/21

Australian AI Company Artrya Announces Major UK Commercialisation Partnership With EVERSANA

Posted on November 8, 202111/8/21

Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership

Posted on November 4, 202111/4/21

Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Posted on October 20, 202110/20/21

EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization

Posted on October 15, 202110/15/21

EVERSANA Acquires Protean; strengthens operational strategy and excellence in market access, channel and patient services

Posted on October 12, 202110/12/21

MINDPAX and EVERSANA announce U.S. commercialization partnership to launch revolutionary digital therapeutic solution for bipolar disorders

Discover EVERSANA

Resource Center
We’re driven by a diverse team of experts who understand the challenges facing today's industry.
Learn More
Experts
We’re driven by a diverse team of experts who understand the challenges facing today's industry.
Experts